secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001493152-25-008808
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals ships first product from new FDA-approved expanded campus
-------------------------------------------------------------------------------

- First lot of finished product shipped from new facility at 144 Ludlow Avenue, Northvale, NJ.
- New packaging line runs at ~120 bottles per minute, adding packaging, inventory and warehouse space.
- Expansion converts existing packaging space into additional manufacturing suites, boosting production capacity.
- Company says new facility positions it to meet projected packaging demand for at least the next five years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225008808/0001493152-25-008808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225008808/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer